- What are sponsors doing now to plan ahead and to position studies to return to full activity as precautions release?
- How can sites prepare for the wave of study restarts? What can be done now- even remotely- to maintain contact with participants, sponsors and vendors?
- What will be different about our research studies, procedures and practices as we move into a post-COVID world?
Most Recent Flipbooks
In a recent webinar, Steven Beales, Senior VP, Scientific and Regulatory at WCG, facilitated a conversation with FDA leaders, discussing overreporting SUSARs and the impact on patient safety.
16 industry experts share shifts and trends that will inform clinical research in 2020 and beyond.